Search

Belinda Kay Wilmer

from Martinsburg, WV
Age ~54
Get Report
Also known as:
Belinda K Wilmer, Belinda Kay Bauers, Belinda K Bauers, Belina Wilmer, Wilmer Belinda, Wilmer Belina
Phone and address:
521 Nathaniel Dr, Martinsburg, WV 25403
(304) 754-5126
Related to:
Harold L Bauers, 84Elvin M Wilmer, 54Robert L Bauers, 52Wilma J Bauers, 81
Connected to:
Adam S Wilmer, 51Anthony D Wilmer, 35Frances F Wilmer, 105Hans H Wilmer, 86Joseph M Wilmer, 50Karen J Wilmer, 74Melonie L Wilmer, 47Precious J Wilmer, 32Robert Wilmer, 55Sonya R Wilmer, 61

Belinda Wilmer Phones & Addresses

  • 521 Nathaniel Dr, Martinsburg, WV 25403 (304) 754-5126
  • Norfolk, VA
  • Frederick, MD
  • Gaithersburg, MD
  • Winter Park, FL
  • Athens, GA

Work

Company: Stb lifesaving technologies - Rockville, MD Sep 2006 Position: Scientist

Education

School / High School: University of Georgia- Athens, GA 1995 Specialities: M.S. in Analytical Chemistry

Industries

Biotechnology

Resumes

Resumes

Belinda Wilmer Photo 1

Belinda Wilmer

View page
Location:
521 Nathaniel Dr, Martinsburg, WV 25403
Industry:
Biotechnology
Work:
Stb Lifesaving Technologies Sep 2006 - Aug 2013
Scientist
In Vitro Technologies Dec 2004 - Jan 2006
Production Scientist
Clearant Sep 2001 - Oct 2004
Research Associate
American Red Cross Nov 1998 - Aug 2001
Research Associate
Old Dominion University May 1997 - Oct 1998
Graduate Research Assistant
Education:
The University of Georgia 1992 - 1995
Master of Science, Masters, Chemistry William & Mary 1988 - 1992
Bachelors, Bachelor of Science, Chemistry
Belinda Wilmer Photo 2

Belinda Wilmer Martinsburg, WV

View page
Work:
STB Lifesaving Technologies
Rockville, MD
Sep 2006 to Aug 2013
Scientist
InVitro Technologies
Baltimore, MD
2004 to 2006
Production Scientist
Clearant, Inc
Gaithersburg, MD
2001 to 2004
Sr. Research Associate
American Red Cross
Rockville, MD
1998 to 2001
Sr. Research Associate
Old Dominion University, Dept of Chemistry and Biochemistry
Norfolk, VA
1997 to 1998
Graduate Research Assistant
USDA Horticulture Research Lab
Orlando, FL
1995 to 1997
Laboratory Technician
University of GA, Department of Chemistry
Athens, GA
1992 to 1995
Graduate Research Assistant/Teaching Assistant
Education:
University of Georgia
Athens, GA
1995
M.S. in Analytical Chemistry
The College of William and Mary
Williamsburg, VA
1992
B.S. in Chemistry

Publications

Us Patents

Methods And Dressings For Sealing Internal Injuries

View page
US Patent:
20090075891, Mar 19, 2009
Filed:
Aug 6, 2008
Appl. No.:
12/222277
Inventors:
Martin MacPhee - Darnestown MD, US
Jerry Kanellos - Eltham, AU
Belinda Wilmer - Martinsburg WV, US
Dawson Beall - Gaithersburg MD, US
International Classification:
A61K 38/36
A61M 37/00
A61P 17/02
US Classification:
514 12, 604500
Abstract:
Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.

Methods And Dressings For Sealing Internal Injuries

View page
US Patent:
20110196421, Aug 11, 2011
Filed:
Apr 5, 2011
Appl. No.:
13/080086
Inventors:
Martin MacPhee - Damestown MD, US
Jerry Kanellos - Victoria, AU
Belinda Wilmer - Martinsburg WV, US
Dawson Beall - Gaithersburg MD, US
International Classification:
A61B 17/03
US Classification:
606213
Abstract:
Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.

Methods And Dressings For Sealing Internal Injuries

View page
US Patent:
20120321692, Dec 20, 2012
Filed:
Feb 7, 2012
Appl. No.:
13/302019
Inventors:
Martin MacPhee - Darnestown MD, US
Jerry Kanellos - Eltham, AU
Belinda Wilmer - Martinsburg WV, US
Dawson Beall - Gaithersburg MD, US
International Classification:
A61K 38/36
A61K 9/127
A61K 38/19
A61K 39/395
A61K 38/48
A61K 38/18
A61K 38/22
A61P 31/00
A61P 7/02
A61P 9/00
A61P 35/00
A61P 31/12
A61P 31/10
A61P 33/00
A61P 29/00
A61P 3/02
A61P 17/02
A61B 17/03
A61K 9/70
US Classification:
424450, 424443, 424 851, 4241301, 4241411, 424 9464, 514 76, 514 97, 514 135, 606213
Abstract:
Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.

Methods For Sterilizing Serum Or Plasma

View page
US Patent:
20040086420, May 6, 2004
Filed:
Jun 13, 2003
Appl. No.:
10/460654
Inventors:
Martin MacPhee - North Potomac MD, US
Dawson Beall - Wheaton MD, US
William Drohan - Springfield VA, US
Belinda Wilmer - Frederick MD, US
Imrana Iqbal - Germantown MD, US
Shirley Miekka - Gaithersburg MD, US
Halina Zbikowska - Lodz, PL
International Classification:
A61L002/08
US Classification:
422/022000, 435/002000
Abstract:
Methods are disclosed for sterilizing serum or plasma to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria, (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. The methods involve sterilizing serum or plasma with irradiation.

Compositions Having Cylindrical Volume, Methods, And Applicators For Sealing Injuries

View page
US Patent:
20210378877, Dec 9, 2021
Filed:
Jan 13, 2021
Appl. No.:
17/148228
Inventors:
- Edmonds WA, US
Dawson BEALL - Germantown MD, US
Jennifer BRICHETTI - Gaithersburg MD, US
Belinda WILMER - Martinsburg WV, US
International Classification:
A61F 13/15
A61L 24/00
A61L 24/10
A61F 13/00
A61F 13/26
A61F 13/20
A61L 15/32
A61L 15/44
Abstract:
Disclosed are solid and frozen haemostatic materials having a rod shape and suitable applicators and plungers for application of such dressings to wounded tissue wherein said dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings, particularly for the treatment of injured tissue via endoscopic or minimally-invasive surgical techniques.

Solid Dressing For Treating Wounded Tissue And Processes For Mixing Fibrinogen And Thrombin While Preserving Fibrin-Forming Ability, Compositions Produced By These Processes, And The Use Thereof

View page
US Patent:
20200000957, Jan 2, 2020
Filed:
Feb 28, 2019
Appl. No.:
16/289535
Inventors:
- Edmonds WA, US
DAWSON BEALL - GAITHERSBURG MD, US
DANIEL GRAHAM - GREENWOOD VILLAGE CO, US
ROB MARTEL - GREENWOOD VILLAGE CO, US
ANGELA MITCHEL - GREENWOOD VILLAGE CO, US
CHRISTINE HAEFLING - GREENWOOD VILLAGE CO, US
PETER BROWN - GREENWOOD VILLAGE CO, US
RICH DEGERONIMO - GREENWOOD VILLAGE CO, US
JERRY KANELLOS - ELTHAM, AU
BELINDA WILMER - MARTINSBURG WV, US
SHIRLEY MIEKKA - COLORADO SPRINGS CO, US
International Classification:
A61L 15/64
A61F 13/02
A61L 26/00
A61L 15/44
A61K 38/36
A61K 38/48
A61L 15/58
A61L 15/38
A61L 15/26
A61F 13/00
A61L 15/18
A61L 15/28
A61L 15/32
A61L 15/22
C08L 89/00
Abstract:
Fibrin Sealant products are used for topical hemostasis and tissue adherence. They are composed of two main reagents, fibrinogen and thrombin. When mixed in solution fibrinogen is converted to fibrin upon the addition of activated thrombin. Therefore typically these two components are stored separately in a lyophilized or liquid state, and mixed, upon or immediately before, application to a patient. While effective, these products require significant preparation that must take place immediately before application, thus delaying treatment and limiting the use of these haemostatic products to the treatment of mild forms of low pressure and low volume bleeding. Attempts to eliminate this delay and expand the usefulness and effectiveness of these products have resulted in products produced by processes that require the separation of these components and their deposition in distinct layers within the product. The processes described herein permit the mixing of fibrinogen and thrombin during product manufacture, without excessive fibrin formation. The resulting ‘pre-mixed’ fibrin sealant material can then be stored in either a frozen or dried state, or suspended in a non-aqueous environment. Activation of the material to form therapeutic fibrin sealant is accomplished by permitting the product to thaw (if frozen) or by the addition of water or other aqueous fluid, including blood, or other bodily fluids, if dried or suspended in a non-aqueous environment. The resulting material can be used to make a product in which a pre-mixed form of activatable fibrin sealant is a desired component.

Methods And Dressings For Sealing Internal Injuries

View page
US Patent:
20190388579, Dec 26, 2019
Filed:
Jan 24, 2019
Appl. No.:
16/256857
Inventors:
- Edmonds WA, US
Jerry KANELLOS - Victoria, AU
Belinda WILMER - Martinsburg WV, US
Dawson BEALL - Gaithersburg MD, US
International Classification:
A61L 15/64
A61L 15/28
A61B 17/00
A61L 15/32
A61K 38/48
A61K 38/36
A61L 15/44
Abstract:
Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.

Hemostatic Compositions And Methods

View page
US Patent:
20190388589, Dec 26, 2019
Filed:
Jan 28, 2019
Appl. No.:
16/259931
Inventors:
- Edmonds WA, US
Belinda WILMER - Martinsburg WV, US
Dawson BEALL - Germantown MD, US
Jennifer Brichetti - Gaithersburg MD, US
International Classification:
A61L 27/54
A61B 17/00
A61L 15/32
A61L 15/38
A61L 15/44
A61B 17/12
A61L 27/26
A61L 27/56
Abstract:
Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings, particularly for the treatment of injured tissue via endoscopic or minimally-invasive surgical techniques.
Control profile
Belinda Kay Wilmer from Martinsburg, WV, age ~54 Get Report